Literature DB >> 19279096

Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome.

Paula Godoy1, Delphine Marsac, Elias Stefas, Pablo Ferrer, Nicole D Tischler, Karla Pino, Pablo Ramdohr, Pablo Vial, Pablo D T Valenzuela, Marcela Ferrés, Francisco Veas, Marcelo López-Lastra.   

Abstract

Hantavirus cardiopulmonary syndrome (HCPS) is a highly pathogenic emerging disease (40% case fatality rate) caused by New World hantaviruses. Hantavirus infections are transmitted to humans mainly by inhalation of virus-contaminated aerosol particles of rodent excreta and secretions. At present, there are no antiviral drugs or immunotherapeutic agents available for the treatment of hantaviral infection, and the survival rates for infected patients hinge largely on early virus recognition and hospital admission and aggressive pulmonary and hemodynamic support. In this study, we show that Andes virus (ANDV) interacts with human apolipoprotein H (ApoH) and that ApoH-coated magnetic beads or ApoH-coated enzyme-linked immunosorbent assay plates can be used to capture and concentrate the virus from complex biological mixtures, such as serum and urine, allowing it to be detected by both immunological and molecular approaches. In addition, we report that ANDV-antigens and infectious virus are shed in urine of HCPS patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279096      PMCID: PMC2682085          DOI: 10.1128/JVI.02409-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Purification and characterization of PCR-inhibitory components in blood cells.

Authors:  W A Al-Soud; P Rådström
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome.

Authors:  G F de Larrañaga; R R Forastiero; L O Carreras; B S Alonso
Journal:  Thromb Res       Date:  1999-10-01       Impact factor: 3.944

3.  Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection.

Authors:  M Kalt; E Gertner
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

4.  Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR.

Authors:  W A Al-Soud; L J Jönsson; P Râdström
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Hantavirus infections: clinical presentation in the emergency room.

Authors:  P Courouble; D Vanpee; E Delgrange; J Donckier; J M Pochet; J B Gillet
Journal:  Eur J Emerg Med       Date:  2001-03       Impact factor: 2.799

6.  Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome.

Authors:  R Schwarzenbacher; K Zeth; K Diederichs; A Gries; G M Kostner; P Laggner; R Prassl
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

7.  Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein.

Authors:  P J Padula; C M Rossi; M O Della Valle; P V Martínez; S B Colavecchia; A Edelstein; S D L Miguel; R D Rabinovich; E L Segura
Journal:  J Med Microbiol       Date:  2000-02       Impact factor: 2.472

8.  Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America.

Authors:  P J Padula; S B Colavecchia; V P Martínez; M O Gonzalez Della Valle; A Edelstein; S D Miguel; J Russi; J M Riquelme; N Colucci; M Almirón; R D Rabinovich
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

9.  Hepatitis B virus Dane particles bind to human plasma apolipoprotein H.

Authors:  I Stefas; M Rucheton; A D D'Angeac; C Morel-Baccard; J M Seigneurin; J P Zarski; M Martin; M Cerutti; J P Bossy; D Missé; H Graafland; F Veas
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

10.  Hantavirus pulmonary syndrome: recognition and emergency department management.

Authors:  S M Dull; J C Brillman; S Q Simpson; D P Sklar
Journal:  Ann Emerg Med       Date:  1994-09       Impact factor: 5.721

View more
  18 in total

1.  Hantavirus Gn and Gc glycoproteins self-assemble into virus-like particles.

Authors:  Rodrigo Acuña; Nicolás Cifuentes-Muñoz; Chantal L Márquez; Manuela Bulling; Jonas Klingström; Roberta Mancini; Pierre-Yves Lozach; Nicole D Tischler
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

Review 2.  Landscape, Climate and Hantavirus Cardiopulmonary Syndrome Outbreaks.

Authors:  Paula Ribeiro Prist; Paulo Sérgio D Andrea; Jean Paul Metzger
Journal:  Ecohealth       Date:  2017-06-15       Impact factor: 3.184

3.  The Andes hantavirus NSs protein is expressed from the viral small mRNA by a leaky scanning mechanism.

Authors:  Jorge Vera-Otarola; Loretto Solis; Ricardo Soto-Rifo; Emiliano P Ricci; Karla Pino; Nicole D Tischler; Théophile Ohlmann; Jean-Luc Darlix; Marcelo López-Lastra
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

4.  Molecular method for the detection of Andes hantavirus infection: validation for clinical diagnostics.

Authors:  Cecilia Vial; Constanza Martinez-Valdebenito; Susana Rios; Jessica Martinez; Pablo A Vial; Marcela Ferres; Juan C Rivera; Ruth Perez; Francisca Valdivieso
Journal:  Diagn Microbiol Infect Dis       Date:  2015-07-29       Impact factor: 2.803

5.  Highly sensitive detection of the group A Rotavirus using Apolipoprotein H-coated ELISA plates compared to quantitative real-time PCR.

Authors:  Cornelia Adlhoch; Marco Kaiser; Marina Hoehne; Andreas Mas Marques; Ilias Stefas; Francisco Veas; Heinz Ellerbrok
Journal:  Virol J       Date:  2011-02-10       Impact factor: 4.099

6.  Infection of human monocyte-derived dendritic cells by ANDES Hantavirus enhances pro-inflammatory state, the secretion of active MMP-9 and indirectly enhances endothelial permeability.

Authors:  Delphine Marsac; Stephanie García; Alexandra Fournet; Adam Aguirre; Karla Pino; Marcela Ferres; Alexis M Kalergis; Marcelo Lopez-Lastra; Francisco Veas
Journal:  Virol J       Date:  2011-05-13       Impact factor: 4.099

7.  Hantaviruses in the americas and their role as emerging pathogens.

Authors:  Brian Hjelle; Fernando Torres-Pérez
Journal:  Viruses       Date:  2010-11-25       Impact factor: 5.048

8.  Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the Virus.

Authors:  Ilias Stefas; Sylvia Tigrett; Grégor Dubois; Marco Kaiser; Estelle Lucarz; Delphine Gobby; Dorothy Bray; Heinz Ellerbrok; Jean Pierre Zarski; Francisco Veas
Journal:  PLoS One       Date:  2015-10-26       Impact factor: 3.240

9.  The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody.

Authors:  Aurelija Zvirbliene; Indre Kucinskaite-Kodze; Ausra Razanskiene; Rasa Petraityte-Burneikiene; Boris Klempa; Rainer G Ulrich; Alma Gedvilaite
Journal:  Viruses       Date:  2014-02-07       Impact factor: 5.048

10.  Rapid enzyme-linked immunosorbent assay for the detection of hantavirus-specific antibodies in divergent small mammals.

Authors:  Karla Cautivo; Tony Schountz; Mariana Acuña-Retamar; Marcela Ferrés; Fernando Torres-Pérez
Journal:  Viruses       Date:  2014-05-06       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.